Cancer Diagnostics Market (Test Type: Tumor Biomarker Tests, Imaging, Endoscopy, and Biopsy; End-user: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Publish Date: Oct 2022

Report Code: TMR2184B

Publisher: Transparency

Single User License: $5795

Explore Our Services

Already a member? Login here.

Report Highlights

Cancer Diagnostics Market – Scope of Report

TMR’s report on the global cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cancer diagnostics market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cancer diagnostics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cancer diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cancer diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global cancer diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cancer diagnostics market.

The report delves into the competitive landscape of the global cancer diagnostics market. Key players operating in the global cancer diagnostics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cancer diagnostics market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market cancer diagnostics.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2031
Growth rate 7.40%
Units considered $ Million
Segments covered By Test Type, By Application, By End User, By Region
Industry covered Healthcare
Countries covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Companies studied
  • Abbott,
  • Eli Lilly and Company,
  • Agilent Technologies, Inc.,
  • Applied DNA Sciences,
  • Becton, Dickinson and Company,
  • bioMerieux SA,
  • Exact Sciences Corporation,
  • F. Hoffmann-La Roche Ltd.,
  • General Electric Company,
  • Hologic, Inc. and Others.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Cancer Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 2 : Global Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 3 : Global Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 4 : Global Cancer Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 5 : North America Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 6 : North America Cancer Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 7 : North America Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 8 : North America Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 9 : Europe Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 10 : Europe Cancer Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 11 : Europe Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 12 : Europe Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 13 : Asia Pacific Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 14 : Asia Pacific Cancer Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 15 : Asia Pacific Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 16 : Asia Pacific Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 17 : Latin America Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18 : Latin America Cancer Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 19 : Latin America Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 20 : Latin America Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 21 : Middle East & Africa Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22 : Middle East & Africa Cancer Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 23 : Middle East & Africa Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2031
  • Table 24 : Middle East & Africa Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Figure 1 : Global Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : Global Cancer Diagnostics Market Value Share, by Test Type, 2021
  • Figure 3 : Global Cancer Diagnostics Market Value Share, by Application, 2021
  • Figure 4 : Global Cancer Diagnostics Market Value Share, by End-user 2021
  • Figure 5 : Global Cancer Diagnostics Market Value Share Analysis, by Test Type 2021 and 2031
  • Figure 6 : Global Cancer Diagnostics Market Attractiveness Analysis, by Test Type, 2022–2031
  • Figure 7 : Global Cancer Diagnostics Market Value (US$ Mn), by Tumor Biomarker Tests, 2017‒2031
  • Figure 8 : Global Cancer Diagnostics Market Value (US$ Mn), by Prostate Specific Antigen Tests, 2017‒2031
  • Figure 9 : Global Cancer Diagnostics Market Value (US$ Mn), by Circulating Tumor Cells (CTC) Tests, 2017‒2031
  • Figure 10 : Global Cancer Diagnostics Market Value (US$ Mn), by Alpha-fetoprotein (AFP) Tests, 2017‒2031
  • Figure 11 : Global Cancer Diagnostics Market Value (US$ Mn), by CA 19-9 Tests, 2017‒2031
  • Figure 12 : Global Cancer Diagnostics Market Value (US$ Mn), by CA 125 Tests, 2017‒2031
  • Figure 13 : Global Cancer Diagnostics Market Value (US$ Mn), by HER2, 2017‒2031
  • Figure 14 : Global Cancer Diagnostics Market Value (US$ Mn), by BRCA, 2017‒2031
  • Figure 15 : Global Cancer Diagnostics Market Value (US$ Mn), by KRAS, 2017‒2031
  • Figure 16 : Global Cancer Diagnostics Market Value (US$ Mn), by Others, 2017‒2031
  • Figure 17 : Global Cancer Diagnostics Market Value (US$ Mn), by Imaging, 2017‒2031
  • Figure 18 : Global Cancer Diagnostics Market Value (US$ Mn), by Magnetic Resonance Imaging (MRI) Scan, 2017‒2031
  • Figure 19 : Global Cancer Diagnostics Market Value (US$ Mn), by Positron Emission Tomography (PET) Scan, 2017‒2031
  • Figure 20 : Global Cancer Diagnostics Market Value (US$ Mn), by Computed Tomography (CT) Scan, 2017‒2031
  • Figure 21 : Global Cancer Diagnostics Market Value (US$ Mn), by Mammography, 2017‒2031
  • Figure 22 : Global Cancer Diagnostics Market Value (US$ Mn), by Others, 2017‒2031
  • Figure 23 : Global Cancer Diagnostics Market Value (US$ Mn), by Endoscopy, 2017‒2031
  • Figure 24 : Global Cancer Diagnostics Market Value (US$ Mn), by Colonoscopy, 2017‒2031
  • Figure 25 : Global Cancer Diagnostics Market Value (US$ Mn), by Bronchoscopy, 2017‒2031
  • Figure 26 : Global Cancer Diagnostics Market Value (US$ Mn), by Others, 2017‒2031
  • Figure 27 : Global Cancer Diagnostics Market Value (US$ Mn), by Biopsy, 2017‒2031
  • Figure 28 : Global Cancer Diagnostics Market Value (US$ Mn), by Bone Marrow Biopsy, 2017‒2031
  • Figure 29 : Global Cancer Diagnostics Market Value (US$ Mn), by Needle Biopsy, 2017‒2031
  • Figure 30 : Global Cancer Diagnostics Market Value (US$ Mn), by Endoscopic Biopsy, 2017‒2031
  • Figure 31 : Global Cancer Diagnostics Market Value (US$ Mn), by Others, 2017‒2031
  • Figure 32 : Global Cancer Diagnostics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 33 : Global Cancer Diagnostics Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 34 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Breast Cancer, 2017–2031
  • Figure 35 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Lung Cancer, 2017–2031
  • Figure 36 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Colorectal Cancer, 2017–2031
  • Figure 37 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Prostate Cancer, 2017–2031
  • Figure 38 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Pancreatic Cancer, 2017–2031
  • Figure 39 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Ovarian Cancer, 2017–2031
  • Figure 40 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Blood Cancer, 2017–2031
  • Figure 41 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Melanoma, 2017–2031
  • Figure 42 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Other Cancers, 2017–2031
  • Figure 43 : Global Cancer Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 44 : Global Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 45 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Hospitals 2017–2031
  • Figure 46 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
  • Figure 47 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Diagnostic Laboratories, 2017–2031
  • Figure 48 : Global Cancer Diagnostics Market Revenue (US$ Mn), by Others, 2017–2031
  • Figure 49 : Global Cancer Diagnostics Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 50 : Global Cancer Diagnostics Market Attractiveness Analysis, by Region, 2022–2031
  • Figure 51 : North America Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 52 : North America Cancer Diagnostics Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 53 : North America Cancer Diagnostics Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 54 : North America Cancer Diagnostics Market Value Share Analysis, by Test Type , 2021 and 2031
  • Figure 55 : North America Cancer Diagnostics Market Attractiveness Analysis, by Test Type 2022–2031
  • Figure 56 : North America Cancer Diagnostics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 57 : North America Cancer Diagnostics Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 58 : North America Cancer Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 59 : North America Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 60 : Europe Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 61 : Europe Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 62 : Europe Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 63 : Europe Cancer Diagnostics Market Value Share Analysis, by Test Type 2021 and 2031
  • Figure 64 : Europe Cancer Diagnostics Market Attractiveness Analysis, by Test Type, 2022–2031
  • Figure 65 : Europe Cancer Diagnostics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 66 : Europe Cancer Diagnostics Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 67 : Europe Cancer Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 68 : Europe Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 69 : Asia Pacific Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 70 : Asia Pacific Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 71 : Asia Pacific Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 72 : Asia Pacific Cancer Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 73 : Asia Pacific Cancer Diagnostics Market Attractiveness Analysis, by Test Type, 2022–2031
  • Figure 74 : Asia Pacific Cancer Diagnostics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 75 : Asia Pacific Cancer Diagnostics Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 76 : Asia Pacific Cancer Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 77 : Asia Pacific Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 78 : Latin America Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 79 : Latin America Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 80 : Latin America Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 81 : Latin America Cancer Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 82 : Latin America Cancer Diagnostics Market Attractiveness Analysis, by Test Type, 2022–2031
  • Figure 83 : Latin America Cancer Diagnostics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 84 : Latin America Cancer Diagnostics Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 85 : Latin America Cancer Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 86 : Latin America Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 87 : Middle East & Africa Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 88 : Middle East & Africa Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 89 : Middle East & Africa Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 90 : Middle East & Africa Cancer Diagnostics Market Value Share Analysis, by Test Type , 2021 and 2031
  • Figure 91 : Middle East & Africa Cancer Diagnostics Market Attractiveness Analysis, by Test Type, 2022–2031
  • Figure 92 : Middle East & Africa Cancer Diagnostics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 93 : Middle East & Africa Cancer Diagnostics Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 94 : Middle East & Africa Cancer Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 95 : Middle East & Africa Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 96 : Company Share Analysis, 2021

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Similar Reports from Transparency

Cancer Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • Date - Oct 2020
  • Code - TMR2184A

Global Cancer Diagnostics Market - Scope of Report

TMR’s report on the global cancer diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cancer diagnostics market for the period 2017–2027, considering 2018 ...

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Cancer Diagnostics Market (Test Type: Tumor Biomarker Tests, Imaging, Endoscopy, and Biopsy; End-user: Hospitals, Ambulatory Surgical Centers, Diagnostic...